On January 21, 2022 ArcticZymes Technologies reported that fourth quarter and the full year 2021 on Thursday, 27 January 2022 at 08.30 a.m (Press release, Biotec Pharmacon, JAN 21, 2022, View Source [SID1234606683]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The company will host an online presentation for investors, analysts, and media at 08:30 a.m. on Thursday, 27 January 2022, which will be followed by a Q&A session.

CEO, Jethro Holter and CFO, Børge Sørvoll will hold the presentation.

Participants who want to participate in the live webcast are asked to send an email to [email protected] for a separate invitation, which will be distributed 1 day prior to the meeting. Participants who want to participate by telephone should dial in on +47 21 40 24 87 with conference id: 141 573 333#. It will be possible to post questions through the webcast and over the phone after the presentation is finished.

The report for the fourth quarter and the full year 2021 will be available on www.newsweb.no and on the company’s homepage www.arcticzymes.com from 07.00 a.m. on Thursday, 27 January 2022.